Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Ascending Dose, Double Blind, Placebo-controlled Study of NAP (AL-108) in Chronic Schizophrenia

NCT00505765 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT00505765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00505765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Ascending Dose, Double Blind, Placebo-controlled Study of NAP (AL-108) in Chronic Schizophrenia
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2007
Completion date
April 30, 2009
Enrollment
63 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia